T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Evergy
EVRG
$18.9B
| $669M | 0.09% |
11,123,939
-2,023,771
| -15% | -$118M |
|
227
Atmos Energy
ATO
$28.6B
| $667M | 0.09% |
6,319,478
-238,714
| -4% | -$24.4M |
|
228
Tapestry
TPR
$32.4B
| $666M | 0.09% |
20,995,907
-953,354
| -4% | -$29.7M |
|
|
COUP
229
DELISTED
Coupa Software Incorporated
COUP
| $665M | 0.09% |
5,251,420
-734,963
| -12% | -$78.9M |
|
230
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
| $660M | 0.09% |
482,859
-2,700
| -0.6% | -$3.57M |
|
231
Incyte
INCY
$24.5B
| $650M | 0.09% |
7,650,522
-7,504
| -0.1% | -$602K |
|
232
Avery Dennison
AVY
$13.6B
| $643M | 0.09% |
5,555,193
+626,277
| +13% | +$68.5M |
|
233
NVR
NVR
$17.1B
| $641M | 0.09% |
190,047
+12,746
| +7% | +$40.9M |
|
234
Analog Devices
ADI
$188B
| $636M | 0.09% |
5,636,929
+3,502,958
| +164% | +$379M |
|
235
Coca-Cola
KO
$372B
| $633M | 0.09% |
12,435,375
+775,566
| +7% | +$38M |
|
|
GLIBA
236
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $629M | 0.09% |
10,236,824
-27,796
| -0.3% | -$1.65M |
|
237
Armstrong World Industries
AWI
$7.89B
| $629M | 0.09% |
6,472,013
+2,338,327
| +57% | +$209M |
|
238
Toro Company
TTC
$9.41B
| $627M | 0.09% |
9,369,283
+32,412
| +0.3% | +$2.28M |
|
239
Credicorp
BAP
$30B
| $627M | 0.09% |
2,737,622
+138,936
| +5% | +$31.9M |
|
240
Assurant
AIZ
$13.9B
| $624M | 0.09% |
5,863,690
+522,617
| +10% | +$51.6M |
|
|
HES
241
DELISTED
Hess
HES
| $622M | 0.09% |
9,785,878
-3,813,573
| -28% | -$236M |
|
242
Abbott
ABT
$190B
| $618M | 0.09% |
7,351,800
-2,926,566
| -28% | -$230M |
|
243
Ulta Beauty
ULTA
$23.3B
| $615M | 0.09% |
1,774,253
+210,475
| +13% | +$72.7M |
|
244
Entegris
ENTG
$23B
| $612M | 0.09% |
16,388,545
+2,391,166
| +17% | +$90.7M |
|
245
GSK
GSK
$102B
| $606M | 0.09% |
12,123,720
-1,363,511
| -10% | -$68.4M |
|
|
INFO
246
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $603M | 0.08% |
9,470,732
+395,560
| +4% | +$22.7M |
|
247
Lennox International
LII
$14.9B
| $603M | 0.08% |
2,192,270
+651,363
| +42% | +$178M |
|
248
Alaska Air
ALK
$5.4B
| $600M | 0.08% |
9,388,675
-326,091
| -3% | -$19.8M |
|
249
Mondelez International
MDLZ
$78.9B
| $596M | 0.08% |
11,063,139
-12,196
| -0.1% | -$633K |
|
|
CLGX
250
DELISTED
Corelogic, Inc.
CLGX
| $596M | 0.08% |
14,246,939
-59,656
| -0.4% | -$2.43M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.